Frankfurt - Delayed Quote EUR

Marker Therapeutics, Inc. (GX1.F)

Compare
2.6200
0.0000
(0.00%)
At close: January 10 at 9:07:20 AM GMT+1
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
--
466.7850
Operating Expense
10,194.7460
14,581.3780
19,791.0040
39,477.9950
28,885.8120
Operating Income
-10,194.7460
-14,581.3780
-19,791.0040
-39,477.9950
-28,419.0270
Net Non Operating Interest Income Expense
564.6030
539.1580
248.0630
5.7000
148.7420
Other Income Expense
--
--
-232.9740
-2,406.5760
31.0000
Pretax Income
-9,630.1430
-14,042.2200
-19,775.9150
-41,878.8710
-28,239.2850
Tax Provision
--
3.6750
--
--
--
Net Income Common Stockholders
-9,696.7570
-8,236.8140
-29,930.6940
-41,878.8710
-28,706.0700
Diluted NI Available to Com Stockholders
-9,696.7570
-8,236.8140
-29,930.6940
-41,878.8710
-28,706.0700
Basic EPS
-1.09
-0.94
-3.58
-5.47
-6.10
Diluted EPS
-1.09
-0.94
-3.58
-5.47
-6.10
Basic Average Shares
8,908.4920
8,809.3820
8,351.0030
7,650.5670
4,703.9860
Diluted Average Shares
8,908.4920
8,809.3820
8,351.0030
7,650.5670
4,703.9860
Total Operating Income as Reported
-10,194.7460
-14,581.3780
-19,791.0040
-39,477.9950
-28,885.8120
Total Expenses
10,194.7460
14,581.3780
19,791.0040
39,477.9950
28,885.8120
Net Income from Continuing & Discontinued Operation
-9,696.7570
-8,236.8140
-29,930.6940
-41,878.8710
-28,706.0700
Normalized Income
-9,633.8180
-14,045.8950
-19,775.9150
-41,878.8710
-28,737.0700
Interest Income
564.6030
539.1580
248.0630
5.7000
148.7420
Net Interest Income
564.6030
539.1580
248.0630
5.7000
148.7420
EBIT
-10,194.7460
-14,581.3780
-19,791.0040
-39,477.9950
-28,419.0270
EBITDA
-10,194.7460
-14,581.3780
-19,791.0040
-36,315.3570
-27,343.3470
Reconciled Depreciation
--
--
3,680.4490
3,162.6380
1,075.6800
Net Income from Continuing Operation Net Minority Interest
-9,633.8180
-14,045.8950
-19,775.9150
-41,878.8710
-28,706.0700
Total Unusual Items Excluding Goodwill
--
--
--
--
31.0000
Total Unusual Items
--
--
--
--
31.0000
Normalized EBITDA
-10,194.7460
-14,581.3780
-19,791.0040
-36,315.3570
-27,374.3470
Tax Rate for Calcs
--
0.0002
--
--
--
12/31/2020 - 12/28/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade